VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 125 filers reported holding VERVE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $9,375,000 | -45.8% | 500,000 | -58.3% | 0.72% | -36.6% |
| Q1 2023 | $17,304,000 | -1.8% | 1,200,000 | +31.7% | 1.14% | +3.7% |
| Q4 2022 | $17,629,998 | -43.7% | 911,111 | 0.0% | 1.10% | -26.2% |
| Q3 2022 | $31,297,000 | +120.9% | 911,111 | -1.7% | 1.49% | +113.8% |
| Q2 2022 | $14,166,000 | -17.2% | 927,100 | +23.6% | 0.70% | -22.7% |
| Q1 2022 | $17,115,000 | -33.7% | 750,000 | +7.1% | 0.90% | -26.1% |
| Q4 2021 | $25,809,000 | -8.5% | 700,000 | +16.7% | 1.22% | -16.2% |
| Q3 2021 | $28,200,000 | -41.0% | 600,000 | -24.4% | 1.46% | -31.2% |
| Q2 2021 | $47,794,000 | – | 793,265 | – | 2.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alphabet Inc. | 10,974,011 | $167,683,000 | 9.10% |
| ARCH Venture Management, LLC | 2,508,809 | $38,335,000 | 4.67% |
| Casdin Capital, LLC | 3,138,167 | $47,951,000 | 4.05% |
| M28 Capital Management LP | 178,500 | $2,727,000 | 3.06% |
| Redmile Group, LLC | 1,833,547 | $28,017,000 | 1.07% |
| Cormorant Asset Management, LP | 700,710 | $10,707,000 | 0.81% |
| Novo Holdings A/S | 927,100 | $14,166,000 | 0.70% |
| Pinz Capital Management, LP | 51,800 | $792,000 | 0.54% |
| PFM Health Sciences, LP | 845,186 | $12,914,000 | 0.49% |
| Artal Group S.A. | 400,000 | $6,112,000 | 0.33% |